Potential Sanofi-Insmed Deal: Analysts Split on Financial Strain Versus Pipeline Gains
Source: Benzinga ·

French pharmaceutical giant Sanofi SA (NASDAQ:SNY) is reportedly exploring a potential acquisition of Insmed Inc. (NASDAQ:INSM). As per a Thursday Bloomberg report, the potential acquisition comes as Sanofi seeks new growth opportunities to reduce its reliance on blockbuster drug
Read the full story at Benzinga
Shared from the GodsView world desk: live wires next to a globe of flights, ships, fires, and quakes.